BioCentury | May 13, 2013
Finance

Dx-ing Dx investing

...the outlook for venture investing in diagnostics. His first blog entry offered a post-mortem of On-Q-ity Inc....
BioCentury | May 6, 2013
Finance

Keep it small

...He said the firm had only invested in four diagnostic plays since 2000 - including On-Q-ity Inc....
BioCentury | May 2, 2013
Tools & Techniques

CTCs gain character(ization)

...Despite the recent shuttering of circulating tumor cell diagnostic company On-Q-ity Inc. , researchers at Massachusetts General...
...most likely to work against metastatic cancer cells in those patients." Atlas had invested in On-Q-ity...
BioCentury | Apr 30, 2012
Clinical News

OnQChip diagnostic data

...double-blind trial analyzing blood samples from 30 cancer patients and 33 healthy controls showed that On-Q-ity's...
...markers captured and detected both epithelial cell adhesion molecule ( EpCAM )-positive and EpCAM-negative CTCs. On-Q-ity...
...count CTCs to determine the prognosis of patients with metastatic prostate, colorectal or breast cancer. On-Q-ity Inc....
BioCentury | Feb 20, 2012
Financial News

On-Q-ity completes venture financing

On-Q-ity Inc. , Waltham, Mass. Business: Diagnostic Date completed: 2/15/12 Type: Venture financing Raised: $5 million Investors: Mohr Davidow Ventures; Atlas Venture; Physic Ventures WIR Staff...
BioCentury | Feb 20, 2012
Company News

Wilex management update

...CSO of Wilex's Wilex Inc. U.S. subsidiary, formerly CSO and interim president and CEO of On-Q-ity Inc. WIR...
BioCentury | Feb 20, 2012
Company News

On-Q-ity management update

On-Q-ity Inc. , Waltham, Mass. Business: Diagnostic, Cancer Hired: Michael Stocum as president and CEO, he is also president and founder of Personalized Medicine Partners LLC WIR Staff cancer Diagnostic...
BioCentury | Aug 8, 2011
Company News

Roche management update

...and former president and CEO of On-Q-ity Inc. , where she will remain as a director; On-Q-ity...
BioCentury | Aug 1, 2011
Company News

Roche hires Aspinall as Ventana president

...and CEO of diagnostics company On-Q-ity Inc. (Waltham, Mass.), where she will remain as a director. On-Q-ity...
BioCentury | Apr 18, 2011
Emerging Company Profile

On-Q-ity: Gently capturing CTCs

...circulating tumor cells but are unable to characterize them and have low sensitivities and specificities. On-Q-ity Inc....
...give more information about the patient's tumor and help researchers discover new biomarkers, Aspinall noted. On-Q-ity's...
...Brunswick, N.J. Laboratory Corp. of America Holdings (NYSE:LH), Burlington, N.C. On-Q-ity Inc. , Waltham, Mass. Sidebars On-Q-ity Inc....
Items per page:
1 - 10 of 23
BioCentury | May 13, 2013
Finance

Dx-ing Dx investing

...the outlook for venture investing in diagnostics. His first blog entry offered a post-mortem of On-Q-ity Inc....
BioCentury | May 6, 2013
Finance

Keep it small

...He said the firm had only invested in four diagnostic plays since 2000 - including On-Q-ity Inc....
BioCentury | May 2, 2013
Tools & Techniques

CTCs gain character(ization)

...Despite the recent shuttering of circulating tumor cell diagnostic company On-Q-ity Inc. , researchers at Massachusetts General...
...most likely to work against metastatic cancer cells in those patients." Atlas had invested in On-Q-ity...
BioCentury | Apr 30, 2012
Clinical News

OnQChip diagnostic data

...double-blind trial analyzing blood samples from 30 cancer patients and 33 healthy controls showed that On-Q-ity's...
...markers captured and detected both epithelial cell adhesion molecule ( EpCAM )-positive and EpCAM-negative CTCs. On-Q-ity...
...count CTCs to determine the prognosis of patients with metastatic prostate, colorectal or breast cancer. On-Q-ity Inc....
BioCentury | Feb 20, 2012
Financial News

On-Q-ity completes venture financing

On-Q-ity Inc. , Waltham, Mass. Business: Diagnostic Date completed: 2/15/12 Type: Venture financing Raised: $5 million Investors: Mohr Davidow Ventures; Atlas Venture; Physic Ventures WIR Staff...
BioCentury | Feb 20, 2012
Company News

Wilex management update

...CSO of Wilex's Wilex Inc. U.S. subsidiary, formerly CSO and interim president and CEO of On-Q-ity Inc. WIR...
BioCentury | Feb 20, 2012
Company News

On-Q-ity management update

On-Q-ity Inc. , Waltham, Mass. Business: Diagnostic, Cancer Hired: Michael Stocum as president and CEO, he is also president and founder of Personalized Medicine Partners LLC WIR Staff cancer Diagnostic...
BioCentury | Aug 8, 2011
Company News

Roche management update

...and former president and CEO of On-Q-ity Inc. , where she will remain as a director; On-Q-ity...
BioCentury | Aug 1, 2011
Company News

Roche hires Aspinall as Ventana president

...and CEO of diagnostics company On-Q-ity Inc. (Waltham, Mass.), where she will remain as a director. On-Q-ity...
BioCentury | Apr 18, 2011
Emerging Company Profile

On-Q-ity: Gently capturing CTCs

...circulating tumor cells but are unable to characterize them and have low sensitivities and specificities. On-Q-ity Inc....
...give more information about the patient's tumor and help researchers discover new biomarkers, Aspinall noted. On-Q-ity's...
...Brunswick, N.J. Laboratory Corp. of America Holdings (NYSE:LH), Burlington, N.C. On-Q-ity Inc. , Waltham, Mass. Sidebars On-Q-ity Inc....
Items per page:
1 - 10 of 23